Previous Article | Next Article ![]()
Journal of Virology, December 2008, p. 11976-11978, Vol. 82, No. 23
0022-538X/08/$08.00+0 doi:10.1128/JVI.01028-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Young Eun Ha,4,5,
Jung Eun Choi,1,3
Jeonghyun Ahn,2,3
Heuiran Lee,2,3
Hee-Seok Kweon,6
Jee-Young Lee,6 and
Dong Hou Kim1,3*
Departments of Anatomy and Cell Biology,1 Microbiology,2 Research Institute for Biomacromolecules, University of Ulsan College of Medicine, Ulsan,3 Department of Medicine, Samsung Medical Center,4 Sungkyunkwan University School of Medicine, Seoul,5 Division of Electron Microscopic Research, Korea Basic Science Institute, Daejeon, South Korea6
Received 15 May 2008/ Accepted 3 September 2008
|
|
|---|
|
|
|---|
Autophagy is a process of sequestering of aberrant organelles or protein aggregates into double-membrane vesicles for lysosomal breakdown. Autophagy has been thought to be a protective mechanism directed against intracellular bacteria and viruses (3). However, it has recently been revealed that some viruses rather induce autophagy to assist in their replication. Such viruses include poliovirus, a member of the picornavirus group (6). In contrast, human rhinovirus type 2, another picornavirus, does not use autophagy during replication (1). Thus, determining whether a particular virus, such as coxsackievirus, uses autophagy during replication is very important for understanding viral tropism and developing therapeutic strategies.
Coxsackievirus B4 (CVB4) was propagated and maintained as described previously (7). Primary rat cortical neuron cultures were prepared, CVB4 was inoculated at 1 PFU per cell at in vitro day 4, and cells were washed with fresh medium after 1 h as described previously (7). Drugs were administered 1 h after virus infection at final concentrations of 10 mM for 3-methyladenine (3-MA), 20 nM for rapamycin, and 100 nM for calpain inhibitors. Western blotting and transmission electron microscopy were performed as described previously (12). Antibodies used in this study were directed against LC3 (1:1,000; MBL), VP1 (1:100; Novocastra), spectrin (1:1,000; BioMol), and β-actin (1:5,000; Sigma).
CVB4 increased LC3-II, the autophagosome marker (9), in a time-dependent manner (Fig. 1A), indicating an increase in autophagosomes in primary rat neurons postinfection. With this increase in LC3-II, levels of VP1 (a virus capsid protein) also rose (Fig. 1A). Treatment with 3-MA, an inhibitor of autophagy induction (10), prevented the increases in both LC3-II and VP1 (Fig. 1A) otherwise seen at 24 h postinfection, showing that the autophagy pathway was involved in CVB4 replication in primary neurons. This finding was confirmed by assaying progeny virus production. Whereas control virus levels reached a maximum of 6.4 x 106 ± 0.12 x 106 PFU/ml, 3-MA decreased this figure to 4.8 x 106 ± 0.27 x 106 PFU/ml (Fig. 1B). Rapamycin, an inducer of autophagy, enhanced the increases in LC3-II and VP1 caused by CVB4 at 48 h postinfection (data not shown), further confirming the involvement of autophagy in CVB4 replication in primary neurons.
![]() View larger version (31K): [in a new window] |
FIG. 1. Changes related to autophagy in CVB4-infected neurons. (A) Western blotting shows that levels of LC3-II, VP1, and the calpain-cleaved spectrin fragment increase in CVB4-infected neurons but decrease in 3-MA-treated neurons. *, P < 0.01 versus the result for CVB4-infected untreated neurons. (B) The assay of progeny virus production and a sequential plaque assay showed that 3-MA decreases virus replication. *, P < 0.01.
|
![]() View larger version (34K): [in a new window] |
FIG. 2. Effects of calpain inhibitors on autophagy and virus production. (A) Western blotting shows that calpain inhibitors prevent increases in LC3-II and VP1 in CVB4-infected neurons. MI, mock infection; calp-i-I and calp-i-III, calpain inhibitors I and III. *, P < 0.01 versus the result for CVB4-infected neurons in the absence of inhibitors. (B) The assay of progeny virus production and a sequential plaque assay showed that calpain inhibitor I decreases virus replication. *, P < 0.01.
|
In accordance with the Western blot analysis of LC3-II levels (Fig. 1 and 2), transmission electron microscopy showed that CVB4 infection resulted in increases in autophagosomal structures surrounded by double membranes (Fig. 3). However, both 3-MA and calpain inhibitor I caused significant decreases in autophagosomal structures (Fig. 3), further confirming the Western blot results.
![]() View larger version (107K): [in a new window] |
FIG. 3. Transmission electron microscopy images. Compared to mock-infected neurons, CVB4-treated neurons show extensive accumulations of autophagosomal structures (arrowheads). The inset is a magnified view of an autophagosomal structure surrounded by a double membrane. The autophagosomal structures were greatly decreased in 3-MA- and calpain inhibitor I (Calp-I)-treated neurons. Negative staining of a cryoelectron microscopy image shows the immunogold labeling of LC3-II on autophagosomal structures (right upper panel). Bar in CVB4+Calp-I image, 500 nm; bars in inset and right upper panel, 100 nm. *, P < 0.01 versus the result for CVB4-infected neurons in the absence of 3-MA and calpain inhibitors.
|
The effects of calpain on the autophagy pathway vary with cell type, the degree of cell starvation, the presence of drugs such as rapamycin, and the nature of the infecting virus. CVB4 requires calpain activation for autophagy induction and virus replication (Fig. 2). However, since the calpain inhibitors could inhibit several other proteinases, more exquisite studies using approaches such as small interfering RNA would clarify this issue more clearly in the future. Interestingly, during the preparation of our manuscript, Upla and colleagues reported that calpain is required for CVB3 replication and suggested that the formation of replication complexes is dependent on calpain activity (11). We suggest here that the autophagosome is one of the CVB4 replication complexes dependent on calpain activity.
Published ahead of print on 17 September 2008. ![]()
S.Y.Y. and Y.E.H. contributed equally to this work. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»